Alex Bastian joins Memo Therapeutics AG as VP Commercial Strategy
27 août 2024 02h00 HE
|
Memo Therapeutics AG
PRESS RELEASE Alex Bastian joins Memo Therapeutics AG as VP Commercial Strategy Seasoned commercial leader with significant international experience Joins ahead of lead development candidate...
Memo Therapeutics AG appoints Paul Carter as Chairperson
08 juil. 2024 07h00 HE
|
Memo Therapeutics AG
PRESS RELEASE Memo Therapeutics AG appoints Paul Carter as Chairperson Virology and commercial expertise will support Phase III readiness and commercial preparations of AntiBKV Extensive public...
Memo Therapeutics AG appoints Paul Carter as Chairperson
08 juil. 2024 02h00 HE
|
Memo Therapeutics AG
PRESS RELEASE Memo Therapeutics AG appoints Paul Carter as Chairperson Virology and commercial expertise will support Phase III readiness and commercial preparations of AntiBKV Extensive public and...
Memo Therapeutics increases Series C financing to CHF 45 million
07 mai 2024 07h00 HE
|
Memo Therapeutics AG
PRESS RELEASE Memo Therapeutics increases Series C financing to CHF 45 million Additional CHF 20 million raised from new investors Ysios Capital and Kurma Partners as well as from existing...
Memo Therapeutics increases Series C financing to CHF 45 million
07 mai 2024 02h00 HE
|
Memo Therapeutics AG
PRESS RELEASE Memo Therapeutics increases Series C financing to CHF 45 million Additional CHF 20 million raised from new investors Ysios Capital and Kurma Partners as well as from existing...
Memo Therapeutics AG Strengthens Management Team
05 févr. 2024 07h00 HE
|
Memo Therapeutics AG
PRESS RELEASE Memo Therapeutics AG Strengthens Management Team Appoints Kristie B. Clemmer as VP Clinical Operations and Dr. Maartje Verschuur as VP CMC and Supply Chain Management ...